NAPLEX Quiz: Drug Concentrations And Ratio Strengths

What this quiz covers

This quiz focuses on Drug Concentrations And Ratio Strengths, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. 1 g diclofenac in 100 g total
2. 5 g diclofenac in 100 g total
3. 2 g diclofenac in 100 g total (correct answer)
4. 0.5 g diclofenac in 100 g total

Explanation: This question tests understanding of ratio strength calculations in pharmaceutical compounding, specifically for topical preparations. The key principle is that a 1:50 ratio strength (w/w) means 1 part active ingredient to 50 parts total product, which equals 2% concentration. The correct answer is C (2 g diclofenac in 100 g total) because 1:50 means 1 g drug per 50 g total product, so for 100 g total, we need 2 g of diclofenac (100 g ÷ 50 = 2 g). Answer A (1 g) would create a 1:100 ratio, too dilute for the prescription. Answer B (5 g) would yield a 1:20 ratio, too concentrated. Answer D (0.5 g) would produce a 1:200 ratio, far below the prescribed strength. When working with ratio strengths, remember that the second number represents total parts, not just the base, and always convert between ratio strength and percentage to verify accuracy. For topical NSAIDs, maintaining the correct concentration ensures therapeutic efficacy while minimizing systemic absorption and adverse effects.

Question 2

1. $25\,\text{units/mL}$
2. $50\,\text{units/mL}$ (correct answer)
3. $100\,\text{units/mL}$
4. $500\,\text{units/mL}$

Explanation: The pharmaceutical calculation concept being tested is calculating the concentration of an anticoagulant IV infusion. The key mathematical principle is dividing total units by total volume to find units/mL. The correct answer 50 units/mL is best because 25,000 units / 500 mL = 50 units/mL, standard for heparin protocols. Choice A 25 units/mL is incorrect, perhaps from halving the units. Choices C 100 units/mL and D 500 units/mL are wrong, from volume errors like using 250 mL or 50 mL. A transferable clinical pearl is to monitor aPTT regularly during heparin therapy. Emphasizing high-alert medication calculations reduces thrombosis risks.

Question 3

1. 1 mL
2. 2 mL (correct answer)
3. 4 mL
4. 5 mL

Explanation: The pharmaceutical calculation concept being tested is calculating the volume of stock solution needed for a diluted IV preparation at a specific concentration and final volume. The key mathematical principle is determining drug amount from final concentration and volume, then dividing by stock concentration. The correct answer 2 mL is best because 10 mg total (from 2 mg/mL × 5 mL) divided by 5 mg/mL stock equals 2 mL needed. Choice A 1 mL is incorrect, halving the required volume and yielding only 5 mg total. Choices C 4 mL and D 5 mL are wrong, providing excess drug like 20 mg or 25 mg, possibly from confusing final and stock concentrations. A transferable clinical pearl is to prepare small-volume IV pushes with precise dilutions to minimize waste. Emphasizing calculation of total dose first ensures safe antiemetic administration.

Question 4

1. $20\,\text{mg/mL}$
2. $40\,\text{mg/mL}$ (correct answer)
3. $50\,\text{mg/mL}$
4. $200\,\text{mg/mL}$

Explanation: The pharmaceutical calculation concept being tested is converting a labeled suspension concentration to mg/mL units. The key mathematical principle is dividing the drug amount by the corresponding volume from the label. The correct answer 40 mg/mL is best because 200 mg divided by 5 mL equals 40 mg/mL, providing the per-milliliter strength. Choice A 20 mg/mL is incorrect, possibly from dividing by 10 mL. Choices C 50 mg/mL and D 200 mg/mL are suboptimal, likely from misinterpreting the label or ignoring the volume. A transferable clinical pearl is to shake suspensions well before measuring to ensure uniform concentration. Emphasizing unit conversions aids accurate pediatric antibiotic dosing.

Question 5

1. $8\,\text{mcg/mL}$
2. $16\,\text{mcg/mL}$
3. $32\,\text{mcg/mL}$ (correct answer)
4. $64\,\text{mcg/mL}$

Explanation: The pharmaceutical calculation concept being tested is calculating the concentration of a vasopressor IV infusion, including unit conversion to mcg/mL. The key mathematical principle is dividing total drug by volume, then converting mg to mcg for clinical relevance. The correct answer 32 mcg/mL is best because 8 mg / 250 mL = 0.032 mg/mL, and 0.032 × 1000 = 32 mcg/mL. Choice A 8 mcg/mL is incorrect, quartering the value perhaps by misdividing. Choices B 16 mcg/mL and D 64 mcg/mL are wrong, from halving or doubling errors in conversion. A transferable clinical pearl is to standardize vasopressor concentrations in ICUs for rapid titration. Emphasizing mcg/mL units prevents overdose in shock management.

Question 6

1. $0.25\,\text{mg/mL}$
2. $1.25\,\text{mg/mL}$
3. $2.5\,\text{mg/mL}$ (correct answer)
4. $12.5\,\text{mg/mL}$

Explanation: This question tests the concept of drug concentration conversion from a labeled ratio to milligrams per milliliter (mg/mL). The key mathematical principle involves dividing the amount of drug by the volume to express the concentration in standardized units, independent of patient-specific factors like weight or labs, which are provided as distractors. The correct answer, 2.5 mg/mL, is the best calculation because dividing 12.5 mg by 5 mL yields exactly 2.5 mg/mL, accurately reflecting the stock solution's concentration without any preparation or dilution implied. Choice A (0.25 mg/mL) is incorrect due to a common error of dividing by 50 instead of 5, perhaps misreading the label; choice B (1.25 mg/mL) might result from halving the correct value or confusing with a different formulation; choice D (12.5 mg/mL) erroneously assumes the label indicates per mL rather than per 5 mL. Always verify units when converting concentrations to avoid dosing errors in pediatric patients. A useful strategy is to double-check calculations by multiplying back: 2.5 mg/mL times 5 mL equals 12.5 mg, confirming accuracy.

Question 7

1. $40\,\text{mg/mL}$
2. $80\,\text{mg/mL}$ (correct answer)
3. $100\,\text{mg/mL}$
4. $400\,\text{mg/mL}$

Explanation: The pharmaceutical calculation concept being tested is converting a labeled concentration to a different unit for oral suspensions. The key mathematical principle is dividing the amount of drug by the volume to find mg/mL, independent of patient-specific dosing. The correct answer 80 mg/mL is best because 400 mg divided by 5 mL equals 80 mg/mL, accurately reflecting the stock concentration. Choice A 40 mg/mL is incorrect, halving the actual strength perhaps by misreading the label. Choices C 100 mg/mL and D 400 mg/mL are wrong, possibly from ignoring the volume or confusing with daily dose calculations. A transferable clinical pearl is to verify suspension concentrations before calculating pediatric doses to avoid under- or overdosing. Emphasizing unit conversions like mg per mL ensures safe dispensing and administration in children.

Question 8

1. $31.25\,\text{mg/mL}$
2. $62.5\,\text{mg/mL}$ (correct answer)
3. $125\,\text{mg/mL}$
4. $250\,\text{mg/mL}$

Explanation: The pharmaceutical calculation concept being tested is determining the concentration after reconstituting a steroid vial with a specified diluent volume. The key mathematical principle is dividing the drug amount by the added diluent volume, assuming negligible powder displacement for simplicity. The correct answer 62.5 mg/mL is best because 125 mg divided by 2 mL equals 62.5 mg/mL, as stated in the reconstitution process. Choice A 31.25 mg/mL is incorrect, perhaps from dividing by 4 mL in error. Choices C 125 mg/mL and D 250 mg/mL are suboptimal, likely from not accounting for dilution or misreading the vial strength. A transferable clinical pearl is to check package inserts for exact reconstitution volumes to account for powder volume. Emphasizing unit consistency in mg/mL prevents errors in corticosteroid dosing.

Question 9

1. 0.4 mL
2. 4 mL (correct answer)
3. 10 mL
4. 40 mL

Explanation: The pharmaceutical calculation concept being tested is calculating the final volume for a diluted opioid injection to reach a target concentration. The key mathematical principle is dividing the dose by the desired concentration. The correct answer 4 mL is best because 4 mg / 1 mg/mL = 4 mL total volume containing the dose. Choice A 0.4 mL is incorrect, matching undiluted stock volume but not the concentration. Choices C 10 mL and D 40 mL are suboptimal, yielding 0.4 mg/mL or 0.1 mg/mL, excessively dilute. A transferable clinical pearl is to monitor respiration after opioid administration. Emphasizing dilution for safety reduces injection risks.

Question 10

1. 1:10
2. 1:50
3. 1:100 (correct answer)
4. 1:1,000

Explanation: The pharmaceutical calculation concept being tested is converting percentage strength to ratio strength for topical solutions. The key mathematical principle is that percent w/v equals grams per 100 mL, so ratio is 1 : (100 / percent). The correct answer 1:100 is best because for 1% w/v, 100 / 1 = 100, meaning 1 part clindamycin in 100 parts total solution. Choice A 1:10 is incorrect, representing 10% which is too concentrated for acne therapy. Choices B 1:50 and D 1:1,000 are wrong, corresponding to 2% and 0.1%, from arithmetic errors like halving or decimal shifts. A transferable clinical pearl is to use w/v for liquids in compounding to match solubility considerations. Emphasizing ratio verification enhances safety in dermatologic preparations.

Question 11

1. 10 mL
2. 20 mL (correct answer)
3. 40 mL
4. 50 mL

Explanation: The pharmaceutical calculation concept being tested is calculating the final volume for a diluted IV diuretic to achieve a target concentration. The key mathematical principle is dividing the dose by the desired concentration to find total volume. The correct answer 20 mL is best because 40 mg / 2 mg/mL = 20 mL, ensuring safe push administration. Choice A 10 mL is incorrect, yielding 4 mg/mL which is too concentrated. Choices C 40 mL and D 50 mL are wrong, resulting in 1 mg/mL or 0.8 mg/mL, unnecessarily dilute. A transferable clinical pearl is to monitor electrolytes post-diuretic administration. Emphasizing stock concentration in dilutions avoids vein irritation.

Question 12

1. 1:4
2. 1:40
3. 1:400 (correct answer)
4. 1:4,000

Explanation: The pharmaceutical calculation concept being tested is converting low-percentage strength to ratio strength for nasal solutions. The key mathematical principle is ratio = 1 : (100 / percent) for w/v concentrations. The correct answer 1:400 is best because for 0.25% w/v, 100 / 0.25 = 400, indicating 1 part phenylephrine in 400 parts solution. Choice A 1:4 is incorrect, equating to 25% which is overly concentrated. Choices B 1:40 and D 1:4,000 are suboptimal, representing 2.5% and 0.025%, from decimal point errors. A transferable clinical pearl is to consider osmolarity in nasal compounds to avoid irritation. Emphasizing precise conversions ensures effective decongestant therapy.

Question 13

1. $0.2\,\text{mg/mL}$
2. $1\,\text{mg/mL}$
3. $2\,\text{mg/mL}$ (correct answer)
4. $20\,\text{mg/mL}$

Explanation: The pharmaceutical calculation concept being tested is determining the final concentration of a vitamin IV admixture. The key mathematical principle is dividing the drug amount by the total volume. The correct answer 2 mg/mL is best because 100 mg / 50 mL = 2 mg/mL, appropriate for withdrawal management. Choice A 0.2 mg/mL is incorrect, perhaps from using 500 mL volume. Choices B 1 mg/mL and D 20 mg/mL are suboptimal, from doubling volume or not dividing. A transferable clinical pearl is to administer thiamine before glucose in alcoholics. Emphasizing mg/mL units ensures proper IV preparation.

Question 14

1. 0.2 mL
2. 2 mL (correct answer)
3. 5 mL
4. 10 mL

Explanation: The pharmaceutical calculation concept being tested is determining the stock volume needed for a diluted sedative IV push given total dose and final volume. The key mathematical principle is dividing the required dose by the stock concentration. The correct answer 2 mL is best because 2 mg / 1 mg/mL = 2 mL of stock, with diluent to reach 10 mL total. Choice A 0.2 mL is incorrect, providing only 0.2 mg which is subtherapeutic. Choices C 5 mL and D 10 mL are wrong, exceeding the dose with 5 mg or 10 mg. A transferable clinical pearl is to administer sedatives slowly to monitor respiratory effects. Emphasizing dose-first calculations prevents procedural errors.

Question 15

1. $0.25\,\text{mg/mL}$
2. $0.5\,\text{mg/mL}$ (correct answer)
3. $1\,\text{mg/mL}$
4. $2\,\text{mg/mL}$

Explanation: The pharmaceutical calculation concept being tested is calculating the final concentration of an IV admixture. The key mathematical principle is dividing the total drug amount by the total volume to obtain mg/mL. The correct answer 0.5 mg/mL is best because 125 mg diltiazem in 250 mL yields 125 / 250 = 0.5 mg/mL, suitable for infusion. Choice A 0.25 mg/mL is incorrect, perhaps from doubling the volume in error. Choices C 1 mg/mL and D 2 mg/mL are suboptimal, likely from halving the volume or miscalculating the numerator. A transferable clinical pearl is to label IV bags with exact concentrations to guide infusion rate adjustments. Emphasizing accuracy in unit consistency prevents dosing errors in critical care settings.

Question 16

1. 6 mL per dose
2. 10 mL per dose
3. 8 mL per dose (correct answer)
4. 4 mL per dose

Explanation: This question tests the calculation of medication volume for pediatric dosing, where accuracy is crucial for therapeutic efficacy and safety. The mathematical principle involves using proportion to determine volume: if 40 mg is in 5 mL, then 64 mg requires proportionally more volume. The correct answer is C (8 mL per dose) because using the proportion 40 mg/5 mL = 64 mg/X mL, solving for X gives 8 mL per dose. Answer A (6 mL) would only provide 48 mg of trimethoprim, subtherapeutic for the infection. Answer B (10 mL) would deliver 80 mg, exceeding the prescribed dose. Answer D (4 mL) would only provide 32 mg, half the required dose. When calculating pediatric doses, always double-check by multiplying the concentration by the calculated volume: 40 mg/5 mL × 8 mL = 64 mg. Educate caregivers to use appropriate measuring devices (oral syringes, not household spoons) to ensure accurate administration of liquid medications.

Question 17

1. 8 mcg/mL
2. 16 mcg/mL (correct answer)
3. 1.6 mcg/mL
4. 160 mcg/mL

Explanation: This question tests the calculation of drug concentration with unit conversion, essential for preparing critical care medications like vasopressors. The key principle is converting between milligrams and micrograms while calculating concentration: 1 mg = 1,000 mcg. The correct answer is B (16 mcg/mL) because 4 mg = 4,000 mcg, and 4,000 mcg ÷ 250 mL = 16 mcg/mL. Answer A (8 mcg/mL) represents a calculation error of halving the concentration. Answer C (1.6 mcg/mL) is a decimal place error, being 10 times too dilute. Answer D (160 mcg/mL) is 10 times too concentrated, likely from incorrect unit conversion. When preparing vasopressor infusions, accurate concentration calculations are critical as small dosing errors can cause severe hemodynamic instability. Always use standardized concentrations when available and verify unit conversions, as norepinephrine is typically dosed in mcg/min requiring precise mcg/mL concentrations.

Question 18

1. 100 mL total final volume (correct answer)
2. 50 mL total final volume
3. 10 mL total final volume
4. 200 mL total final volume

Explanation: This question tests the calculation of dilution volume for a narrow therapeutic index drug (fosphenytoin), where precise concentration is essential for safe administration. The key principle is using the dilution formula: Final volume = Amount of drug / Desired concentration. The correct answer is A (100 mL total final volume) because 1,000 mg PE ÷ 10 mg PE/mL = 100 mL total volume needed. Answer B (50 mL) would create a concentration of 20 mg PE/mL, too concentrated for safe infusion. Answer C (10 mL) would yield 100 mg PE/mL, dangerously concentrated. Answer D (200 mL) would produce 5 mg PE/mL, unnecessarily dilute and increasing infusion time. When preparing narrow therapeutic index drugs like fosphenytoin, maintaining the correct concentration prevents infusion-related adverse effects such as hypotension and cardiac arrhythmias. Always calculate the volume of concentrated drug needed (20 mL in this case) and subtract from total volume to determine diluent volume (80 mL).

Question 19

1. 1:10
2. 1:100 (correct answer)
3. 1:1,000
4. 10:1

Explanation: The pharmaceutical calculation concept being tested is converting percentage to ratio strength for antifungal creams. The key mathematical principle is ratio strength as 1 : (100 / percent) for w/w formulations. The correct answer 1:100 is best because for 1% w/w, 100 / 1 = 100, indicating 1 part clotrimazole in 100 parts cream. Choice A 1:10 is incorrect, matching 10% which is too potent. Choices C 1:1,000 and D 10:1 are suboptimal, representing 0.1% or reverse ratio errors. A transferable clinical pearl is to counsel on application duration for topicals. Emphasizing w/w basis ensures compounding accuracy.

Question 20

1. Add 10 mL diluent
2. Add 20 mL diluent
3. Add 30 mL diluent
4. Add 40 mL diluent (correct answer)

Explanation: The pharmaceutical calculation concept being tested is diluting a concentrated injection to a desired concentration while calculating added diluent volume. The key mathematical principle is determining total volume from dose and target concentration, then subtracting the stock volume to find diluent needed. The correct answer add 40 mL diluent is best because 10 mL of 50 mg/mL provides 500 mg, and 500 mg / 10 mg/mL = 50 mL total, so 50 - 10 = 40 mL diluent. Choices A, B, and C (10, 20, 30 mL) are incorrect, resulting in higher concentrations like 50, 25, or 16.7 mg/mL, risking precipitation or irritation. These distractors often stem from forgetting to subtract the stock volume or miscalculating the initial amount. A transferable clinical pearl is to consider drug solubility limits when diluting anticonvulsants like phenytoin. Emphasizing step-by-step verification of volumes ensures safe IV administration.